NUWE
Price
$4.88
Change
-$0.01 (-0.20%)
Updated
Sep 5 closing price
Capitalization
4.41M
PRE
Price
$8.09
Change
+$0.08 (+1.00%)
Updated
Sep 5 closing price
Capitalization
105.44M
Interact to see
Advertisement

NUWE vs PRE

Header iconNUWE vs PRE Comparison
Open Charts NUWE vs PREBanner chart's image
Nuwellis
Price$4.88
Change-$0.01 (-0.20%)
Volume$22.31K
Capitalization4.41M
Prenetics Global
Price$8.09
Change+$0.08 (+1.00%)
Volume$16.21K
Capitalization105.44M
NUWE vs PRE Comparison Chart in %
Loading...
NUWE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NUWE vs. PRE commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUWE is a Hold and PRE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (NUWE: $4.88 vs. PRE: $8.09)
Brand notoriety: NUWE and PRE are both not notable
NUWE represents the Medical/Nursing Services, while PRE is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NUWE: 2% vs. PRE: 40%
Market capitalization -- NUWE: $4.41M vs. PRE: $105.44M
NUWE [@Medical/Nursing Services] is valued at $4.41M. PRE’s [@Medical Specialties] market capitalization is $105.44M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.68B. The average market capitalization across the [@Medical Specialties] industry is $10.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NUWE’s FA Score shows that 1 FA rating(s) are green whilePRE’s FA Score has 2 green FA rating(s).

  • NUWE’s FA Score: 1 green, 4 red.
  • PRE’s FA Score: 2 green, 3 red.
According to our system of comparison, PRE is a better buy in the long-term than NUWE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NUWE’s TA Score shows that 4 TA indicator(s) are bullish while PRE’s TA Score has 5 bullish TA indicator(s).

  • NUWE’s TA Score: 4 bullish, 3 bearish.
  • PRE’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PRE is a better buy in the short-term than NUWE.

Price Growth

NUWE (@Medical/Nursing Services) experienced а -4.31% price change this week, while PRE (@Medical Specialties) price change was +6.24% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.04%. For the same industry, the average monthly price growth was +4.21%, and the average quarterly price growth was +24.44%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.01%. For the same industry, the average monthly price growth was +8.25%, and the average quarterly price growth was +13.64%.

Industries' Descriptions

@Medical/Nursing Services (-0.04% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Medical Specialties (+1.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRE($105M) has a higher market cap than NUWE($4.41M). PRE has higher P/E ratio than NUWE: PRE (1.06) vs NUWE (0.01). PRE YTD gains are higher at: 39.483 vs. NUWE (-89.532). NUWE has higher annual earnings (EBITDA): -3.84M vs. PRE (-59.21M). PRE has more cash in the bank: 58.5M vs. NUWE (4.45M). NUWE has less debt than PRE: NUWE (438K) vs PRE (5.15M). PRE has higher revenues than NUWE: PRE (41.5M) vs NUWE (8.32M).
NUWEPRENUWE / PRE
Capitalization4.41M105M4%
EBITDA-3.84M-59.21M6%
Gain YTD-89.53239.483-227%
P/E Ratio0.011.061%
Revenue8.32M41.5M20%
Total Cash4.45M58.5M8%
Total Debt438K5.15M9%
FUNDAMENTALS RATINGS
NUWE: Fundamental Ratings
NUWE
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NUWEPRE
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
65%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
57%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
54%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
57%
Advances
ODDS (%)
Bullish Trend 24 days ago
80%
Bullish Trend 5 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
61%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
NUWE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HSQVY11.210.04
+0.36%
Husqvarna AB
SWPFF2.69N/A
N/A
Swire Properties Ltd.
CYDX0.25N/A
N/A
CYduct Diagnostics Inc.
LCHTF14.09N/A
N/A
LIvechat Software SA
LIMX2.05-0.44
-17.67%
Limitless X Holdings Inc.

NUWE and

Correlation & Price change

A.I.dvisor tells us that NUWE and CORBF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NUWE and CORBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUWE
1D Price
Change %
NUWE100%
-0.20%
CORBF - NUWE
24%
Poorly correlated
N/A
PRE - NUWE
24%
Poorly correlated
+1.00%
BNR - NUWE
23%
Poorly correlated
-1.78%
HSDT - NUWE
23%
Poorly correlated
-0.92%
BVS - NUWE
22%
Poorly correlated
+1.27%
More